Anisomycin sensitizes non‐small‐cell lung cancer cells to chemotherapeutic agents and epidermal growth factor receptor inhibitor via suppressing PI3K/Akt/mTOR-Reference-Cited by-同舟云学术

Anisomycin sensitizes non‐small‐cell lung cancer cells to chemotherapeutic agents and epidermal growth factor receptor inhibitor via suppressing PI3K/Akt/mTOR

Published:2020-12-31 Issue:5 Volume:35 Page:822-831
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Tan Hongxia¹²,Hu Biao³,Xie Fan²,Zhu Chuanbing²,Cheng Zhenshun¹^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine Zhongnan Hospital of Wuhan University 169 Donghu Rd, Wuchang District Wuhan Hubei 430071 China

2. Department of Respiratory and Critical Care Medicine The Second Clinical Medical College Yangtze University 1 Nanhuan Road Jingzhou Hubei 434000 China

3. Department of Orthopaedics Jingzhou Central Hospital The Second Clinical Medical College Yangtze University 1 Nanhuan Road Jingzhou Hubei 434000 China

Funder

National Natural Science Foundation of China

Beijing Medical and Health Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12641

Reference30 articles.

1. Lung Cancer Statistics

2. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy